Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Apr 7;1(6168):920–921. doi: 10.1136/bmj.1.6168.920

Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.

C J Smith, P C Kelleher, L Bélanger, L Dallaire
PMCID: PMC1598569  PMID: 86375

Abstract

Alpha-fetoprotein (AFP) concanavallin-A-affinity molecular variant patterns were determined in amniotic fluid samples from 10 pregnancies complicated by anencephaly (6), spina bifida (1), Turner's syndrome (1), osteogenesis imperfecta congenita (1), and fetal death (1) and 20 normal pregnancies between 14.6 and 25.5 weeks of gestation. With the exception of one anencephalic pregnancy, the AFP concentrations in samples from women with a fetal abnormality were more than 5 SD above normal for gestational age. In every case, however, the proportion of total amniotic fluid AFP that was not reactive with concanavallin A was significantly smaller in the presence of a fetal abnormality (mean 2%) than when the fetus was normal (mean 20%). The results suggest that measuring the amount of concanavallin-A-non-reactive amniotic fluid AFP will be a valuable test for diagnosing fetal abnormality, especially when an increase in total amniotic fluid AFP concentration is equivocal or gestational age is uncertain.

Full text

PDF
920

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belanger L., Hamel D., Dufour D., Pouliot M. Double-antibody enzyme immunoassay applied to human alpha 1-fetoprotein. Clin Chem. 1976 Feb;22(2):198–204. [PubMed] [Google Scholar]
  2. Brock D. J. Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities. Lancet. 1976 Aug 14;2(7981):345–346. doi: 10.1016/s0140-6736(76)92597-6. [DOI] [PubMed] [Google Scholar]
  3. Brock D. J. Prenatal diagnosis - chemical methods. Br Med Bull. 1976 Jan;32(1):16–20. doi: 10.1093/oxfordjournals.bmb.a071317. [DOI] [PubMed] [Google Scholar]
  4. Brock D. J., Sutcliffe R. G. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet. 1972 Jul 29;2(7770):197–199. doi: 10.1016/s0140-6736(72)91634-0. [DOI] [PubMed] [Google Scholar]
  5. Kimball M. E., Milunsky A., Alpert E. Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. Obstet Gynecol. 1977 May;49(5):532–536. [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Seller M. J., Dumon J. E., Vanderheyden J. S. Amniotic fluid AFP in multiple pregnancy. Br Med J. 1977 Jun 18;1(6076):1600–1600. doi: 10.1136/bmj.1.6076.1600-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Smith C. J., Kelleher P. C. Alpha-fetoprotein and albumin in experimentally-induced exencephaly in the rat. Teratology. 1977 Aug;16(1):71–78. doi: 10.1002/tera.1420160112. [DOI] [PubMed] [Google Scholar]
  9. Smith C. J., Morris H. P., Kelleher P. C. Concanavalin A affinity molecular variants of alpha-fetoprotein in neonatal rat serum and in the serum of rats bearing hepatomas. Cancer Res. 1977 Aug;37(8 Pt 1):2651–2656. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES